Study of the Safety of Intravenous Artesunate

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

Not specified

Study Completion Date

October 31, 2006

Conditions
MalariaMalaria, Cerebral
Interventions
DRUG

Intravenous artesunate

Trial Locations (1)

20814-4799

Uniformed Services University of the Health Sciences, Bethesda

All Listed Sponsors
lead

U.S. Army Medical Research and Development Command

FED

NCT00292929 - Study of the Safety of Intravenous Artesunate | Biotech Hunter | Biotech Hunter